Congratulations to Dr. Diego Maselli and Dr. Antonio Anzueto for co-authoring an article published in CHEST.
Clinical Epidemiology of COPD Insights From 10 Years of the COPDGene Study The Genetic Epidemiology of COPD (COPDGene) study is a noninterventional, multicenter, longitudinal analysis of > 10,000 subjects, including smokers with a $ 10 pack-year history with and without COPD and healthy never smokers. The goal was to characterize disease-related phenotypes and explore associations […]Read more
A UT Health San Antonio lung specialist is the first in Texas to use a new genomic test to better and less invasively diagnose a patient with idiopathic pulmonary fibrosis (IPF), a serious, chronic, progressive and scarring lung disease with an average survival time of less than five years after diagnosis…….Read more>>>> Source: MD […]Read more
SAN ANTONIO — There are 70,000 people in the world with cystic fibrosis. 30,000 of them are here in the U.S. In this Wear The Gown, we take you into the only “CF” clinic in San Antonio that takes care of patients from birth, all the way into adulthood. “Cystic fibrosis is a genetic disease […]Read more
The story below features research Anoop Nambiar, M.D., M.S., on a new class of drugs called senolytics that were studied in relation to idiopathic pulmonary fibrosis. Dr. Nambiar is a professor of medicine and founding director of the Interstitial Lung Disease Program at UT Health San Antonio. Two other faculty members are mentioned in the […]Read more
SAN ANTONIO — A local woman nearly lost her battle with a rare lung disease because it had gone undiagnosed. But it was her persistence to get help ultimately saved her life. Angela Michelle Ramos has a new lease on life. She’s working out and getting in shape; something that, until now, was out of […]Read more
Small pilot study points to feasibility of larger trials in age-related diseases UT Health San Antonio researchers, collaborating with the Mayo Clinic and the Wake Forest School of Medicine, are the first to publish results on the treatment of a deadly age-related disease in human patients with drugs called senolytics. The findings were posted Jan. […]Read more
A UT Health San Antonio lung specialist is the first in Texas to use a new genomic test to better and less invasively diagnose a patient with idiopathic pulmonary fibrosis (IPF), a serious chronic, progressive and scarring lung disease with an average survival time of less than five years after diagnosis.Read more